JP2010512779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512779A5 JP2010512779A5 JP2009542273A JP2009542273A JP2010512779A5 JP 2010512779 A5 JP2010512779 A5 JP 2010512779A5 JP 2009542273 A JP2009542273 A JP 2009542273A JP 2009542273 A JP2009542273 A JP 2009542273A JP 2010512779 A5 JP2010512779 A5 JP 2010512779A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant
- strand rna
- segmented
- rna virus
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001493065 dsRNA viruses Species 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06292025.1 | 2006-12-22 | ||
| EP06292025.1A EP1939214B1 (en) | 2006-12-22 | 2006-12-22 | Cells and methodology to generate non-segmented negative-strand RNA viruses |
| PCT/IB2007/004444 WO2008078198A2 (en) | 2006-12-22 | 2007-12-21 | Cells and methodology to generate non-segmented negative-strand rna viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014169418A Division JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512779A JP2010512779A (ja) | 2010-04-30 |
| JP2010512779A5 true JP2010512779A5 (enExample) | 2014-10-16 |
| JP5902371B2 JP5902371B2 (ja) | 2016-04-13 |
Family
ID=37831098
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542273A Active JP5902371B2 (ja) | 2006-12-22 | 2007-12-21 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
| JP2014169418A Pending JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014169418A Pending JP2015015955A (ja) | 2006-12-22 | 2014-08-22 | 非分節型マイナス鎖ｒｎａウイルスを作出するための細胞及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8586364B2 (enExample) |
| EP (2) | EP1939214B1 (enExample) |
| JP (2) | JP5902371B2 (enExample) |
| KR (1) | KR101469007B1 (enExample) |
| CN (2) | CN101631798A (enExample) |
| BR (1) | BRPI0719469C1 (enExample) |
| CA (1) | CA2673262C (enExample) |
| DK (2) | DK1939214T3 (enExample) |
| ES (2) | ES2423518T3 (enExample) |
| MX (1) | MX2009006755A (enExample) |
| WO (1) | WO2008078198A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1375512T3 (da) | 2002-06-20 | 2009-10-26 | Pasteur Institut | Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger |
| EP1375670B1 (en) | 2002-06-20 | 2013-06-12 | Institut Pasteur | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| CA2432738A1 (en) | 2003-02-26 | 2004-08-26 | Philippe Despres | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| WO2012038832A2 (en) * | 2010-09-24 | 2012-03-29 | Institut Pasteur | Generation of replicating chimeric measles virus - retrovirus particles |
| CN103906843B (zh) * | 2011-06-08 | 2016-12-07 | 维什瓦斯·乔希 | 双质粒哺乳动物表达系统 |
| FR2994697B1 (fr) * | 2012-08-24 | 2016-05-13 | Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) | Souche vaccinale marquee du virus de la peste des petits ruminants, et son procede d'obtention |
| EP2712871A1 (en) | 2012-09-27 | 2014-04-02 | Institut Pasteur | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications |
| EP2759301A1 (en) | 2013-01-24 | 2014-07-30 | Institut Pasteur | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-DeltaC virus) |
| US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
| WO2015092710A1 (en) | 2013-12-19 | 2015-06-25 | Glaxosmithkline Biologicals, S.A. | Contralateral co-administration of vaccines |
| EP3242939A4 (en) | 2015-01-05 | 2018-10-17 | Seagull BioSolutions Pvt. Ltd. | Dna molecules producing custom designed replicating and non-replicating negative stranded rna viruses and uses there of |
| EP3184119A1 (en) | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatography based purification strategies for measles scaffold based viruses |
| EP3255056A1 (en) * | 2016-06-06 | 2017-12-13 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | Method for producing self-assemblying paramyxoviral nucleocapsid-like particles and their uses |
| US11351246B2 (en) | 2017-05-09 | 2022-06-07 | Invectys SAS | Recombinant measles vaccine expressing hTERT |
| EP3412307A1 (en) | 2017-06-07 | 2018-12-12 | Institut Pasteur | Recombinant measles virus expressing zika virus proteins and their applications |
| CN107557340A (zh) * | 2017-09-26 | 2018-01-09 | 南京普菲科医药科技有限公司 | 一种可诱导性拯救弹状病毒的细胞系及其构建方法与应用 |
| SG11202004234SA (en) | 2017-11-09 | 2020-06-29 | Pasteur Institut | A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition |
| AU2018392826B2 (en) | 2017-12-21 | 2025-10-09 | Centre National De La Recherche Scientifique | Lassa vaccine |
| EP3820884B1 (en) * | 2018-07-13 | 2025-09-03 | Valneva SE | Method for rescuing and producing a virus in avian cells |
| CN109355301A (zh) * | 2018-08-22 | 2019-02-19 | 深圳大学 | 一种石斑鱼重组NNVcp的密码子优化的核酸序列、融合表达载体、制备方法及其本身 |
| CN111218474A (zh) * | 2018-11-23 | 2020-06-02 | 成都生物制品研究所有限责任公司 | 一种副粘病毒的拯救系统和副粘病毒拯救方法 |
| EP3673917A1 (en) | 2018-12-28 | 2020-07-01 | Themis Bioscience GmbH | Norovirus vaccines |
| CN109913423A (zh) * | 2019-03-27 | 2019-06-21 | 扬州大学 | 一种稳定表达猪德尔塔冠状病毒N蛋白的重组Vero细胞系及应用 |
| CA3166811A1 (en) | 2020-02-13 | 2021-08-19 | Nicolas Robert Xavier Escriou | Measles-vectored covid-19 immunogenic compositions and vaccines |
| EP3865180A1 (en) | 2020-02-13 | 2021-08-18 | Institut Pasteur | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses |
| EP4142786A4 (en) * | 2020-04-27 | 2024-06-19 | Ohio State Innovation Foundation | LIVE ATTENUATED MEASLES VIRUS VACCINE AGAINST SARS-COV-2 |
| EP3936517A1 (en) * | 2020-07-08 | 2022-01-12 | Institut Pasteur | An improved measles virus vaccine vector based on multiple tandem additional transcription units |
| CA3204201A1 (en) | 2021-01-13 | 2022-07-21 | Thierry Heidmann | Measles-hiv or measles-htlv vaccine |
| US20250304921A1 (en) * | 2022-05-27 | 2025-10-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Reverse genetics system for feline morbillivirus |
| EP4501946A1 (en) | 2023-07-31 | 2025-02-05 | LoopLab Bio GmbH | Self-amplifying biologics for targeted therapy |
| WO2026013289A1 (en) | 2024-07-12 | 2026-01-15 | Institut Pasteur | Measles-mumps-rubella (mmr) vaccines |
| CN120648655B (zh) * | 2025-08-21 | 2026-02-13 | 内蒙古自治区农牧业科学院 | 一株t7-293t细胞及其在牛副流感病毒3型感染性克隆拯救病毒中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181112T1 (de) * | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| HK1050210B (en) | 1999-10-12 | 2007-08-24 | Institut Pasteur | Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| JP2004503233A (ja) | 2000-06-16 | 2004-02-05 | インスティティ・パスツール | デング熱ウイルスエンベロープ糖タンパク質のプロ−アポトーシスフラグメント |
| EP1375670B1 (en) | 2002-06-20 | 2013-06-12 | Institut Pasteur | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| DE10234579A1 (de) * | 2002-07-30 | 2004-02-12 | Zf Friedrichshafen Ag | Getriebe |
| EP1633860A2 (en) * | 2003-06-09 | 2006-03-15 | Wyeth | IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| CA2549188A1 (fr) | 2003-12-02 | 2005-06-23 | Universite Paris 7 | Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras |
| FR2870126B1 (fr) | 2004-05-17 | 2009-07-17 | Pasteur Institut | Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin |
| JP2008535868A (ja) * | 2005-04-14 | 2008-09-04 | ザ ユニバーシティー オブ クイーンズランド | 免疫調節組成物およびそのための使用 |
-
2006
- 2006-12-22 ES ES06292025T patent/ES2423518T3/es active Active
- 2006-12-22 DK DK06292025.1T patent/DK1939214T3/da active
- 2006-12-22 EP EP06292025.1A patent/EP1939214B1/en active Active
-
2007
- 2007-12-21 US US12/448,468 patent/US8586364B2/en active Active
- 2007-12-21 BR BRPI0719469A patent/BRPI0719469C1/pt active IP Right Grant
- 2007-12-21 CN CN200780047473A patent/CN101631798A/zh active Pending
- 2007-12-21 CN CN201510019183.6A patent/CN104745533A/zh active Pending
- 2007-12-21 CA CA2673262A patent/CA2673262C/en active Active
- 2007-12-21 JP JP2009542273A patent/JP5902371B2/ja active Active
- 2007-12-21 MX MX2009006755A patent/MX2009006755A/es active IP Right Grant
- 2007-12-21 DK DK07870468.1T patent/DK2091962T3/en active
- 2007-12-21 ES ES07870468.1T patent/ES2686168T3/es active Active
- 2007-12-21 KR KR1020097015426A patent/KR101469007B1/ko active Active
- 2007-12-21 EP EP07870468.1A patent/EP2091962B1/en active Active
- 2007-12-21 WO PCT/IB2007/004444 patent/WO2008078198A2/en not_active Ceased
-
2013
- 2013-10-15 US US14/054,748 patent/US9499799B2/en active Active
-
2014
- 2014-08-22 JP JP2014169418A patent/JP2015015955A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512779A5 (enExample) | ||
| Cowan et al. | Enhancing the functional properties of thermophilic enzymes by chemical modification and immobilization | |
| JP2011062217A5 (enExample) | ||
| JP2015119730A5 (enExample) | ||
| JP2022503959A5 (enExample) | ||
| NZ590144A (en) | Influenza virus-like particles (vlps) comprising hemagglutinin | |
| WO2007002008A3 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
| JP2010227108A5 (enExample) | ||
| JP2018520654A5 (enExample) | ||
| WO2007124327A3 (en) | Methods and compositions for expressing negative-sense viral rna in canine cells | |
| JP2007175057A5 (enExample) | ||
| JP2012503478A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| JP2010279377A5 (enExample) | ||
| WO2010040526A8 (de) | Lcmv-gp-vsv-pseudotypvektoren und tumorinfiltrierende virenproduzentenzellen zur therapie von tumoren | |
| JP2011525793A5 (enExample) | ||
| PH12013502600A1 (en) | Rabies virus like particle production in plants | |
| WO2008129971A1 (ja) | 改良された持続感染型センダイウイルスベクター | |
| WO2013049121A3 (en) | Recombinant phage and methods | |
| Pejman et al. | Gradient-based hybrid topology/shape optimization of bioinspired microvascular composites | |
| MX2018006627A (es) | Aumentar el rendimiento de particulas similares a virus en plantas. | |
| WO2009099877A3 (en) | Closterovirus vectors and methods | |
| JP2021520815A5 (enExample) | ||
| EA201400192A1 (ru) | Клетка, ферментирующая пентозы | |
| CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado |